Healthcare

The 340B program is a lifesaver. Congress should protect it from Big Pharma

By
Published July 7, 2023 4:00am ET
Add Washington Examiner on Google
The 340B program is a lifesaver. Congress should protect it from Big Pharma
The House provision would allow a pharmacist to make a small amount of a drug in preparation for getting a prescription from a doctor, a practice called "office use" compounding. (Sean Meyers/CVS Health via AP Images) | CVS Health


The pharmaceutical industry’s relentless, astronomically expensive campaign to smear the 340B Drug Pricing Program — one of the world’s most important humanitarian programs — knows no bounds. Our healthcare safety net is under attack.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

AIDS Congress Pharmaceutical Industry